SCHEMBL15401337

SCHEMBL15401337

CCOc1ccc(-c2csc(N)n2)c(OCC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.62
KMT2A Q03164 5/20 0.62
PARP1 P09874 1/20 0.50
SMN1; SMN2 Q16637 6/20 0.47
KDM4E B2RXH2 5/20 0.47
TP53 P04637 4/20 0.47
LMNA P02545 1/20 0.47
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP1A1 P04798 1/20 0.47
CYP1B1 Q16678 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 2/20 0.46
MAPT P10636 5/20 0.45
THRB P10828 2/20 0.45
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
POLB P06746 2/20 0.44
TYR P14679 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1821573 0.78 CYP1A1 (0.75) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL30557661 0.78 CYP1A1 (0.75) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL7403707 0.77 RAB9A (0.68) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL11137533 0.76 MAPT (0.50) MEN1KMT2APARP1SMN1; SMN2KDM4E
SCHEMBL14085522 0.75 TP53 (0.49) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL24358021 0.75 MEN1 (0.52) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL10486211 0.75 LMNA (0.49) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL2381338 0.75 MEN1 (0.49) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL29601739 0.75 MEN1 (0.52) MEN1KMT2ASMN1; SMN2KDM4ETP53
SCHEMBL1415660 0.73 ALDH1A1 (0.60) MEN1KMT2ASMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424912-A1 2-AMINOTHIAZOLE DERIVATIVES FOR MEDICAL USE Huazhong University of Science and Technology (CN) 2019-01-09 EP disclosed
US-9771340-B2 2-aminothiazole derivatives and methods of preparing and using the same WUHAN INNAMUNE PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 US disclosed
CN-102336720-B Thiazolamine derivative and preparation method and application HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-01-13 CN disclosed
EP-2682390-A1 2-AMINOTHIAZOLE DERIVATIVE, PREPARATION METHOD, AND USE Huazhong University of Science and Technology (CN) 2014-01-08 EP disclosed
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD. (CN) 2014-01-02 US disclosed
CN-102336720-A 2-aminothiazole derivatives, and preparation method and application thereof UNIV HUAZHONG SCIENCE TECH 2012-02-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME CCNT1, CCNE1, CCNT2 MEN1 847/4885KMT2A 188/4885PARP1 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.